CHEMOEMBOLIZATION

作品数：200被引量：1474H指数：20
导出分析报告
相关领域：医药卫生农业科学更多>>
相关作者：张福君张亮吴沛宏顾仰葵赵明更多>>
相关机构：中山大学第二军医大学四川省医学科学院(四川省人民医院)吉林省肿瘤医院更多>>
相关期刊：更多>>
相关基金：国家自然科学基金广东省自然科学基金上海市科学技术委员会资助项目上海市科学技术发展基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Drug-eluting beads chemoembolization combined with programmed cell death 1 inhibitor and lenvatinib for large hepatocellular carcinoma
《World Journal of Gastrointestinal Oncology》2024年第11期4392-4401,共10页Hui Yang Guang-Ping Qiu Jie Liu Tie-Quan Yang 
BACKGROUND The combination of transarterial chemoembolization(TACE),lenvatinib,and programmed cell death 1(PD-1)inhibitor has been widely used in the treatment of advanced hepatocellular carcinoma(HCC)and has achieved...
关键词：Large hepatocellular carcinoma Conventional transarterial chemoembolization Drug-eluting beads transarterial chemoembolization Programmed cell death 1 inhibitor Lenvatinib 
Improving clinical outcomes of patients with hepatocellular carcinoma:Role of antiviral therapy,conversion therapy,and palliative therapy
《World Journal of Gastrointestinal Oncology》2024年第10期4037-4041,共5页Vishal G Shelat 
In this editorial,I comment on three articles published in the recent issue of the World Journal of Gastrointestinal Oncology.Hepatocellular carcinoma(HCC)is an important public health concern,and there are three arti...
关键词：ANTIVIRALS CHEMOEMBOLIZATION Conversion therapy Hepatocellular carcinoma Lenvatinib Neutrophil-to-lymphocyte ratio 
Application of Cone-beam Computed Tomography in Interventional Therapies for Liver Malignancy:A Consensus Statement by the Chinese College of Interventionalists
《Journal of Clinical and Translational Hepatology》2024年第10期886-891,共6页Bin-Yan Zhong Zhong-Zhi Jia Wen Zhang Chang Liu Shi-Hong Ying Zhi-Ping Yan Cai-Fang Ni Clinical Guidelines Committee of Chinese College of Interventionalists 
Despite its crucial role in interventional therapies for liver malignancy,cone-beam computed tomography(CBCT)has not yet been fully integrated into clinical practice due to several complicating factors,including nonst...
关键词：Cone-beam computed tomography Interventional radiology Liver malignancy Consensus statement CHEMOEMBOLIZATION Ablation 
Impact of neoadjuvant multimodal therapy in the setting of locally advanced hepatocellular carcinoma
《World Journal of Gastroenterology》2024年第28期3452-3455,共4页Daniele Ferraro Federica Falaschi Luca Nazzaro Giovanni Vennarecci 
Immunotherapy and the implementation of more aggressive treatment schemes for locally advanced hepatocellular carcinomas have expanded the boundaries of curative options.Because of these advancements,patients who were...
关键词：Hepatocellular carcinoma IMMUNOTHERAPY RADIOEMBOLIZATION CHEMOEMBOLIZATION Liver transplantation Liver resection 
Meta-analysis of transarterial chemoembolization combined with cryoablation vs transarterial chemoembolization alone for≥5 cm hepatocellular carcinoma
《World Journal of Gastrointestinal Oncology》2024年第6期2793-2803,共11页Jie-Fei Cheng Qiu-Lian Sun Ling Tang Xin-Jian Xu Xiang-Zhong Huang 
BACKGROUND Hepatocellular carcinoma(HCC)ranks sixth globally in cancer incidence and third in mortality rates.Unfortunately,over 70% of HCC patients forego the opportunity for curative surgery or liver transplantation...
关键词：Hepatic cancer CRYOABLATION CHEMOEMBOLIZATION Transarterial chemoembolization Meta analysis 
Analysis of the Effects of Preoperative Hepatic Artery Chemoembolization and Quality Nursing Intervention on the Perioperative Safety and Short-term Prognosis of Liver Transplantation in Patients with Hepatocellular Carcinoma
《Journal of Clinical and Nursing Research》2024年第4期375-380,共6页Yang Wang Zixi Wang Yibo Liu Aochen Wu Baowang Liu Jinglin Cao Yanmin Shi 
Objective: To investigate the effects of preoperative hepatic artery chemoembolization (TACE) and quality nursing interventions on the perioperative safety and short-term prognosis in patients with hepatocellular carc...
关键词：Hepatocellular carcinoma Liver transplantation Hepatic artery chemoembolization Quality nursing intervention 
Global similarities: comparison of the Korean Liver Cancer Association chemoembolization guidelines for hepatocellular carcinoma to the National Comprehensive Cancer Network, American Association for the Study of Liver Diseases and Barcelona Clinic Liver Cancer recommendations
《Hepatobiliary Surgery and Nutrition》2024年第2期343-346,共4页Meaghan S.Dendy Case Daniel B.Brown 
Hepatocellular carcinoma(HCC)remains the third most common cause of cancer-related deaths worldwide(1).Transarterial chemoembolization(TACE)has been established as a therapeutic option in those patients who are outsid...
关键词：Hepatocellular carcinoma(HCC) therapeutic chemoembolization interventional radiology 
Comparative study between Embosphere®and Marine gel®as embolic agents for chemoembolization of hepatocellular carcinoma
《World Journal of Gastrointestinal Oncology》2024年第1期102-109,共8页Hyo-Cheol Kim Jin Woo Choi 
BACKGROUND While gelatin sponge particles and calibrated microspheres are commonly used as embolic materials in conventional transarterial chemoembolization(cTACE),direct comparisons between these embolic agents are r...
关键词：Hepatocellular carcinoma CHEMOEMBOLIZATION Temporary embolic material Permanent embolic material Tumor response 
Chemoembolization with Degradable Starch Microspheres (DSM-TACE): expanding indications in HCC multidisciplinary tumor board
《Hepatoma Research》2023年第1期447-464,共18页Umberto Rozzanigo Francesco Gatti Giacomo Luppi Lorenzo Costa Benedetto Petralia Cecilia Pravadelli Ivana Maioli Michela Frisinghelli Sergio Fersino Riccardo Berletti Giovanni de Pretis Alberto Brolese 
The role of transarterial chemoembolization(TACE)in hepatocellular carcinoma(HCC)management has changed over the last twenty years.There has been a trend towards an overall decline in TACE procedures,but with a more a...
关键词：DSM-TACE CHEMOEMBOLIZATION degradable starch microspheres 
Transarterial Chemoembolization Combined with Apatinib for Treatment of Advanced Hepatocellular Carcinoma:Analysis of Survival and Prognostic Factors被引量：2
《Current Medical Science》2022年第5期1015-1021,共7页Zi-yi LIU Xue-feng KAN Li-jie ZHANG Joyman MAKAMURE Qing LI Dan ZHAO Guo-feng ZHOU Gan-sheng FENG Chuan-sheng ZHENG Bin LIANG 
supported by the National Natural Science Foundation of China(No.81771950,No.81471765 and No.81601578).
Objective Apatinib is a novel inhibitor of vascular endothelial growth factor receptor-2.The goal of this study was to evaluate overall survival(OS)after a combination of transarterial chemoembolization(TACE)and apati...
关键词：CHEMOEMBOLIZATION THERAPEUTIC apatinib molecular targeted therapy SURVIVAL factor analysis STATISTICAL 
全选清除导出
共20页<12345678910>
检索报告 对象比较 聚类工具 使用帮助 返回顶部